Compass Therapeutics (CMPX) Change in Accured Expenses (2018 - 2026)
Compass Therapeutics recorded quarterly Change in Accured Expenses of -$3.4 million in Q1 2026, down 225.34% quarter-over-quarter from $2.7 million in Q4 2025, and down 148.84% year-over-year from $6.9 million in Q1 2025.
Compass Therapeutics' Change in Accured Expenses history runs 9 years deep, the most recent figure standing at -$3.4 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 148.84% year-over-year to -$3.4 million; the TTM figure through Mar 2026 stood at -$5.2 million (down 145.74% YoY), while the FY2025 annual figure was $5.1 million, up 35.06% from the prior year.
- Change in Accured Expenses came in at -$3.4 million for Q1 2026 at Compass Therapeutics, down from $2.7 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $6.9 million in Q1 2025 to a low of -$5.4 million in Q2 2022.
- A 5-year average of -$45588.2 and a median of -$1.1 million in 2023 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses sank 12354.55% in 2022 and surged 1090.99% in 2025, its largest moves.
- Compass Therapeutics' Change in Accured Expenses stood at $5.9 million in 2022, then sank by 152.62% to -$3.1 million in 2023, then surged by 207.7% to $3.4 million in 2024, then decreased by 19.93% to $2.7 million in 2025, then tumbled by 225.34% to -$3.4 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$3.4 million, $2.7 million, and -$2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - | -3.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.38 Mn |
| Mar 31, 2026 | -3.38 Mn |
| Dec 31, 2025 | 2.70 Mn |
| Dec 31, 2025 | 2.70 Mn |
| Sep 30, 2025 | -2.31 Mn |
| Sep 30, 2025 | -2.31 Mn |
| Jun 30, 2025 | -2.22 Mn |
| Jun 30, 2025 | -2.22 Mn |
| Mar 31, 2025 | 6.93 Mn |
| Mar 31, 2025 | 6.93 Mn |
| Dec 31, 2024 | 3.37 Mn |
| Dec 31, 2024 | 3.37 Mn |
| Sep 30, 2024 | -4.31 Mn |
| Sep 30, 2024 | -4.31 Mn |
| Jun 30, 2024 | 5.41 Mn |
| Jun 30, 2024 | 5.41 Mn |
| Mar 31, 2024 | -699,000.00 |
| Mar 31, 2024 | -699,000.00 |
| Dec 31, 2023 | -3.13 Mn |
| Dec 31, 2023 | -3.13 Mn |
| Sep 30, 2023 | -2.18 Mn |
| Sep 30, 2023 | -2.18 Mn |
| Jun 30, 2023 | -1.12 Mn |
| Jun 30, 2023 | -1.12 Mn |
| Mar 31, 2023 | -2.75 Mn |
| Mar 31, 2023 | -2.75 Mn |
| Dec 31, 2022 | 5.95 Mn |
| Dec 31, 2022 | 5.95 Mn |
| Sep 30, 2022 | 2.95 Mn |
| Sep 30, 2022 | 2.95 Mn |
| Jun 30, 2022 | -5.39 Mn |
| Jun 30, 2022 | -5.39 Mn |
| Mar 31, 2022 | -595,000.00 |
| Mar 31, 2022 | -595,000.00 |
| Dec 31, 2021 | 6.59 Mn |
| Dec 31, 2021 | 6.59 Mn |
| Sep 30, 2021 | 825,000.00 |
| Sep 30, 2021 | 825,000.00 |
| Jun 20, 2021 | 44,000.00 |
| Jun 20, 2021 | 44,000.00 |
| Mar 31, 2021 | -442,000.00 |
| Mar 31, 2021 | -442,000.00 |
| Sep 30, 2020 | -1.85 Mn |
| Sep 30, 2020 | -1.85 Mn |
| Jun 30, 2020 | -2.00 Mn |
| Jun 30, 2020 | -2.00 Mn |
| Mar 31, 2020 | -2.07 Mn |
| Mar 31, 2020 | -2.07 Mn |
| Dec 31, 2019 | 6,840.00 |
| Dec 31, 2019 | 6,840.00 |
| Sep 30, 2019 | 401,000.00 |
| Sep 30, 2019 | 401,000.00 |
| Jun 30, 2019 | 11,462.00 |
| Jun 30, 2019 | 11,462.00 |
| Dec 31, 2018 | -125.00 |
| Dec 31, 2018 | -125.00 |
| Jun 30, 2018 | 580.00 |
| Jun 30, 2018 | 580.00 |